Association between depression and maintenance medication adherence among Medicare beneficiaries with chronic obstructive pulmonary disease

International Journal of Geriatric Psychiatry

Volumn 29, Issue 1, 2014, Pages 49-57

  Qian, Jingjing ^a   Simoni Wastila, Linda ^b   Rattinger, Gail B ^c   Zuckerman, Ilene H ^b   Lehmann, Susan ^d   Wei, Yu Jung J ^b   Stuart, Bruce ^b  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chronic obstructive pulmonary disease; depression; maintenance medication; maintenance medication adherence; Medicare beneficiaries

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; MALE; MEDICARE; MEDICATION COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; DEPRESSION; MAINTENANCE MEDICATION; MAINTENANCE MEDICATION ADHERENCE; MEDICARE BENEFICIARIES;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; HUMANS; MAINTENANCE CHEMOTHERAPY; MALE; MEDICARE; MEDICATION ADHERENCE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84890128246     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.3968     Document Type: Article

References (41)

1. American Thoracic Society. 2004. American Thoracic Society and European Respiratory Society standards for the diagnosis and management of patients with COPD. Accessed August 25, 2009.
2. Centers for Disease Control and Prevention. 2008. Deaths: preliminary data. Available at http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59-02.pdf. Accessed February 15, 2011.
3. Chronic Condition Data Warehouse. 2012. 27 chronic condition alogrithms. Buccaneer Computer Systems & Services, Inc., Available at http://www.ccwdata.org/cs/groups/public/documents/document/ccw- conditioncategories2011.pdf. Accessed August 15, 2012.
4. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). 2008. Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2008). Accessed August 25, 2009.
5. Almagro P, Calbo E, Ochoa De Echaguen A, et al. 2002. Mortality after hospitalization for COPD. Chest, 121, 1441-8.
6. Borson S, Mcdonald GJ, Gayle T, et al. 1992. Improvement in mood, physical symptoms, and function with nortriptyline for depression in patients with chronic obstructive pulmonary disease. Psychosomatics, 33, 190-201.
7. Bosley CM, Corden ZM, Rees PJ, Cochrane GM,. 1996. Psychological factors associated with use of home nebulized therapy for COPD. Eur Respir J, 9, 2346-50.
8. Charles MS, Blanchette CM, Silver H, et al. 2010. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin, 26, 2421-9.
9. Choudhry NK, Shrank WH, Levin RL, et al. 2009. Measuring concurrent adherence to multiple related medications. Am J Manag Care, 15, 457-64.
10. Ciechanowski PS, Katon WJ, Russo JE,. 2000. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med, 160, 3278-85.
11. Dimatteo MR, Haskard KB, Williams SL,. 2007. Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care, 45, 521-8.
12. Dimatteo MR, Lepper HS, Croghan TW,. 2000. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med, 160, 2101-7.
13. Hansen RA, Dusetzina SB, Song L, Gaynes BN, et al. 2009. Depression affects adherence measurement but not the effectiveness of an adherence intervention in heart failure patients. J Am Pharm Assoc (2003), 49, 760-8.
14. Jung E, Pickard AS, Salmon JW, Bartle B, Lee TA,. 2009. Medication adherence and persistence in the last year of life in COPD patients. Respir Med, 103, 525-34.
15. Karve S, Cleves MA, Helm M, et al. 2008. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care, 46, 1125-33.
16. Khdour MR, Hawwa AF, Kidney JC, et al. 2012. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD). Eur J Clin Pharmacol, 68, 1365-73.
17. Kunik ME, Roundy K, Veazey C, et al. 2005. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest, 127, 1205-11.
18. Lacasse Y, Beaudoin L, Rousseau L, Maltais F, 2004. Randomized trial of paroxetine in end-stage COPD. Monaldi Arch Chest Dis, 61, 140-7.
19. Lacasse Y, Rousseau L, Maltais F,. 2001. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil, 21, 80-6.
20. Lin EH, Katon W, Von Korff M, et al. 2004. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care, 27, 2154-60.
21. Maurer J, Rebbapragada V, Borson S, et al. 2008. Anxiety and depression in COPD: current understanding, unanswered questions, and research needs. Chest, 134, 43S-56S.
22. Mehuys E, Boussery K, Adriaens E, et al. 2010. COPD management in primary care: an observational, community pharmacy-based study. Ann Pharmacother, 44, 257-66.
23. Morgan AL, Masoudi FA, Havranek EP, et al. 2006. Difficulty taking medications, depression, and health status in heart failure patients. J Card Fail, 12, 54-60.
24. Ng TP, Niti M, Tan WC, et al. 2007. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med, 167, 60-7.
25. Peterson AM, Nau DP, Cramer JA, et al. 2007. A checklist for medication compliance and persistence studies using retrospective databases. Value Health, 10, 3-12.
26. Rand CS,. 2005. Patient adherence with COPD therapy. Eur Respir Rev, 14, 97-101.
27. Restrepo RD, Alvarez MT, Wittnebel LD, et al. 2008. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis, 3, 371-84.
28. Smoller JW, Pollack MH, Systrom D, Kradin RL,. 1998. Sertraline effects on dyspnea in patients with obstructive airways disease. Psychosomatics, 39, 24-9.
29. Spiegelman D, Hertzmark E,. 2005. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol, 162, 199-200.
30. Stuart B, Simoni-Wastila L, Zuckerman I, et al. 2007. Medication use by age and disabled Medicare beneficiaries across the spectrum of morbidity-a chartbook. The Peter Lamy Center on Drug Therapy and Aging, University of Maryland School of Pharmacy, Baltimore, MD.
31. Stuart BC, Simoni-Wastila L, Zuckerman IH, et al. 2010. Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother, 8, 441-53.
32. Toy EL, Beaulieu NU, Mchale JM, et al. 2011. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med, 105, 435-41.
33. Troosters T, Celli B, Lystig T, et al. 2010. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J, 36, 65-73.
34. Van Manen JG, Bindels PJ, Dekker FW, et al. 2002. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax, 57, 412-6.
35. Vestbo J, Anderson JA, Calverley PM, et al. 2009. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 64, 939-43.
36. Xu W, Collet JP, Shapiro, S, et al. 2008. Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med, 178, 913-20.
37. Yohannes AM, Baldwin RC, Connolly M,. 2002. Mortality predictors in disabling chronic obstructive pulmonary disease in old age. Age Ageing, 31, 137-40.
38. Yohannes AM, Baldwin RC, Connolly MJ,. 2000. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry, 15, 1090-6.
39. Yohannes AM, Connolly MJ, Baldwin RC,. 2001. A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease. Int J Geriatr Psychiatry, 16, 451-4.
40. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ,. 2010. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry, 25, 1209-21.
41. Zeng F, Patel BV, Andrews L, Frech-Tamas F, Rudolph AE,. 2010. Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin, 26, 2877-87.